Intellia Therapeutics Inc (NTLA) poses a Brand-New Opportunity for Investors with beta value of 1.85
Intellia Therapeutics Inc (NASDAQ: NTLA) open the trading on Thursday, with a bit cautious approach as it glided -0.84% to $21.32, before settling in for